Approved Products

Through partnerships with the world's leading biopharmaceutical companies, Nektar has enabled highly successful products in a number of therapeutic areas that are used by medical professionals and patients across the globe.

Products Status Indication Partner Therapeutic Area
Cimzia® Approved in U.S. Crohn's disease
Rheumatoid Arthritis
UCB Pharma Immunology
MIRCERA® Approved in EU/U.S. Anemia in chronic kidney disease (CKD) Roche Nephrology
Neulasta® Approved Neutropenia Amgen Oncology
PEGASYS® Approved Hepatitis C Roche Immunology
PEG-INTRON® Approved Hepatitis C Schering-Plough Immunology
DEFINITY® Vial Approved Diagnostic Bristol-Myers Squibb Surgical/Imaging
DuraSeal® Approved Cranial Durant Sealant Confluent Surgical Surgical/Imaging
Somavert® Approved Acromegaly Pfizer Immunology
Macugen® Approved Wet age-related macular degeneration OSI pharmaceuticals Ocular

Return to top »

* Cimzia® is a registered trademark of UCB; MIRCERA® is a registered trademark of Roche; Neulasta® is a registered trademark of Amgen; PEGASYS® is a registered trademark of Roche; PEG-INTRON® is a registered trademark of Schering-Plough; DEFINITY® is a registered trademark of Bristol-Myers Squibb; DuraSeal® is a registered trademark of Confluent Surgical; Somavert® is a registered trademark of Pfizer and Macugen® is a registered trademark of OSI Pharmaceuticals.

 
 
Site Map Privacy Terms of Use Compliance Policy Trademarks Site Users Guide